Piperidine derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2010209825 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Knust, Henner; Nettekoven, Matthias; Ratni, Hasane; Riemer, Claus; Vifian, Walter

Agent Spruson & Ferguson

Pub. Number AU-A-2010209825

PCT Pub. Number WO2010/086259

Priority 09151722.7 30.01.09 EP

Filing date 19 January 2010

Wipo publication date 5 August 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/086259 Priority application(s): WO2010/086259

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209838-Transparent, weather-resistant barrier film, production by lamination, extrusion lamination or extrusion coating

2010209816-Aroylamino - and heteroaroylamino-substituted piperidines as GlyT-1 inhibitors